Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1989-7-31
|
pubmed:abstractText |
mAb have been derived against NK cell-sensitive target cells in an effort to identify the target cell structure involved in Ag recognition by NK cells. Several mAb were selected for further study based on their preliminary target cell binding characteristics. Flow cytometry demonstrated that each of these mAb bound to a series of NK-sensitive target cells of various origins (e.g., K562 and Molt-4) while having little or no reactivity with several NK-resistant target cell lines (e.g., SB and Daudi). Functional studies revealed that two of the mAb were able to inhibit the lysis of NK-sensitive K562 target cells by freshly isolated, endogenous NK cells in a dose-dependent fashion. Further, these mAb also could inhibit the killing of K562 target cells by both activated NK cells and cultured lymphokine-activated killer cells, as well as the cytolysis of other NK-sensitive target cells by each of these effector cell populations. Control experiments with another mAb which bound to the target cells but did not inhibit lysis implied that the effects of these mAb on NK cell function was not the result of steric hindrance. Single cell conjugate assays demonstrated that the mAb inhibited NK cell lysis via the inhibition of binding (recognition). Biochemical analysis of this target cell structure revealed that it was a molecule of approximately 42 kDa which may exist as a homodimer in its native state. Thus, it appears that the mAbs identify an unique Ag on the surface of NK cell-sensitive target cells which is involved in NK cell Ag recognition.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
143
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
727-35
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2738407-Adolescent,
pubmed-meshheading:2738407-Adult,
pubmed-meshheading:2738407-Antibodies, Monoclonal,
pubmed-meshheading:2738407-Antigen-Antibody Reactions,
pubmed-meshheading:2738407-Antigens, Surface,
pubmed-meshheading:2738407-Binding, Competitive,
pubmed-meshheading:2738407-Cell Communication,
pubmed-meshheading:2738407-Cell Line,
pubmed-meshheading:2738407-Cells, Cultured,
pubmed-meshheading:2738407-Cytotoxicity Tests, Immunologic,
pubmed-meshheading:2738407-Humans,
pubmed-meshheading:2738407-Killer Cells, Natural,
pubmed-meshheading:2738407-Male,
pubmed-meshheading:2738407-Molecular Weight
|
pubmed:year |
1989
|
pubmed:articleTitle |
Identification of a human natural killer cell target cell antigen with monoclonal antibodies.
|
pubmed:affiliation |
Center for Environmental Medicine and Lung Biology, University of North Carolina, Chapel Hill 27599.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|